Cipla sees highest patent filings and grants during September in Q3 2023
Cipla saw the highest growth of 199% in patent filings in September and 99% in grants in July in Q3 2023. Compared to Q2 2023, Q3 2023 saw an increase in patent filings by 24% and grants by 99%. GlobalData's DataBook provides a comprehensive analysis of Cipla's patent filings and grants. Buy the databook here.Cipla has been focused on protecting inventions in Australia(AU) with 2 publications in Q3 2023The Australia(AU) Patent Office dominates the patent filings and grants with nearly 25% filings and 33% grants. The World Intellectual Property Organization(WIPO), Australia(AU), United States(US), and Canada(CA) patent Office are among the top ten patent offices where Cipla is filings its patents. Among the top granted patent authorities, Cipla has 33% of its grants in Australia(AU), 33% in Canada(CA), and 33% in European Patent Office(EPO).Johnson & Johnson could be the strongest competitor for CiplaJohnson & Johnson and F. Hoffmann-La Roche secured the top positions according to recent patent publication data.Patents related to climate change and lead Cipla's portfolioCipla has the highest number of patents in climate change followed by, and . For climate change, nearly 100% of patents were filed and 0% of patents were granted in Q3 2023.Manufacturing/industrial related patents lead Cipla portfolio followed by multiple sclerosis, and secondary progressive multiple sclerosis (spms)Cipla has highest number of patents in manufacturing/industrial followed by multiple sclerosis, secondary progressive multiple sclerosis (spms), fungal meningitis and . For manufacturing/industrial, nearly 25% of patents were filed and 0% of patents were granted in Q3 2023.For comprehensive analysis of Cipla's filings and grants, buy the databook here.
Access and buy GlobalData’s databook on the latest filings and grants activity for Cipla here.
What's Your Reaction?
